Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques

Nature Medicine

Volumn 10, Issue 3, 2004, Pages 290-293

  Haagmans, Bart L ^a   Kuiken, Thijs ^a   Martina, Byron E ^a   Fouchier, Ron A M ^a   Rimmelzwaan, Guus F ^a   Van Amerongen, Geert ^a   Van Riel, Debby ^a   De Jong, Ton ^a   Itamura, Shigeyuki ^b   Chan, Kwok Hung ^c   Tashiro, Masato ^b   Osterhaus, Albert D M E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2B; ALPHA2A INTERFERON; ALPHA2B INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALFA-2A; PEGINTERFERON ALFA-2B; PEGINTERFERON ALPHA2A; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LOWER RESPIRATORY TRACT; LUNG ALVEOLUS CELL TYPE 1; MACACA; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VERO CELL; VIRUS REPLICATION; ANIMAL; CYTOLOGY; DRUG EFFECT; HUMAN; IMMUNOLOGY; LUNG ALVEOLUS; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

ANIMALIA; CORONAVIRUS; MACACA; MACACA FASCICULARIS; RNA VIRUSES; SARS CORONAVIRUS; STRAWBERRY CRINKLE VIRUS;

ANIMALS; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; MACACA FASCICULARIS; POLYETHYLENE GLYCOLS; PULMONARY ALVEOLI; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS REPLICATION;

EID: 2342645538     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1001     Document Type: Article

References (29)

1. Fouchier, R.A.M. et al. Koch's postulates fulfilled for SARS virus. Nature 423, 240 (2003).
2. Kuiken, T. et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362, 263-270 (2003).
3. Marra, M.A. et al. The genome sequence of the SARS-associated coronavirus. Science 300, 1399-1404 (2003).
4. Rota, P.A. et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300, 1394-1399 (2003).
5. Drosten, C. et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1967-1976 (2003).
6. Ksiazek, T.G. et al. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1953-1966 (2003).
7. Peiris, J.S.M. et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361, 1319-1325 (2003).
8. Tsang, K.W. et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348, 1977-1985 (2003).
9. Lee, N. et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348, 1986-1994 (2003).
10. Poutanen, S.M. et al. Identification of severe acute respiratory syndrome in Canada. N. Engl. J. Med. 348, 1995-2005 (2003).
11. Nicholls, J.M. et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 361, 1773-1778 (2003).
12. Ware, L.B. & Matthay, M.A. The acute respiratory distress syndrome. N. Engl. J. Med. 342, 1334-1349 (2000).
13. Williams, M.C. The alveolar epithelium: structure and study by immunohistochemistry. in Electron Microscopy of the Lung (ed. Schraufnagel, D.E.) 121-147 (Marcel Dekker, New York, 1990).
14. Bellum, S.C. et al. Respiratory reovirus 1/L induction of intraluminal fibrosis. A model for the study of bronchiolitis obliterans organizing pneumonia. Am. J. Pathol. 150, 2243-2254 (1997).
15. London, L. et al. Respiratory reovirus I/L induction of diffuse alveolar damage: pulmonary fibrosis is not modulated by corticosteroids in acute respiratory distress syndrome in mice. Clin. Immunol. 103, 284-295 (2002).
16. Pei, J., Sekellick, M.J., Marcus, P.I., Choi, I.S. & Collisson, E.W. Chicken interferon type I inhibits infectious bronchitis virus replication and associated respiratory illness. J. Interferon Cytokine Res. 21, 1071-1077 (2001).
17. Smith, A.L., Barthold, S.W. & Beck, D.S. Intranasally administered α/β interferon prevents extension of mouse hepatitis virus, strain JHM, into the brains of BALB/cByJ mice Ant. Res. 8, 239-245 (1987).
18. Turner, R.B., Felton, A., Kosak, K., Kelsey, D.K. & Meschievitz, C.K. Prevention of experimental coronavirus colds with intranasal α-2b interferon. J. Infect. Dis. 154, 443-447 (1986).
19. Manns, M.P. et al. Peginterferon α-2b plus ribavirin compared with interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358, 958-965 (2001).
20. Cinatl, J. et al. Treatment of SARS with human interferons. Lancet 362, 293-294 (2003).
21. Bukowski, R.M. et al. Treating cancer with PEG Intron: pharmacokinetic profile and dosing guidelines for an improved interferon-α2b formulation. Cancer 95, 389-396 (2002),
22. Van Gool, A.R. et al. Serum amino acids, biopterin and neopterin during long-term immunotherapy with interferon-α in high-risk melanoma patients. Psychiatry Res. 119, 125-132 (2003).
23. Franks, T.J. et al. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum. Pathol. 34, 743-748 (2003).
24. Bedrossian, C.W., Sussman, J., Conklin, R.H. & Kahan, B. Azathioprine-associated interstitial pneumonitis. Am. J. Clin. Path. 82, 148-154 (1984).
25. Biron, C.A. Interferons α and β as immune regulators: a new look. Immunity 14, 661-664 (2001).
26. Finter, N.B. & Oldham, R.K. (eds.) Interferons: In Vivo and Clinical Studies. Vol. 4 (Elsevier, Amsterdam, 1985).
27. Booth, C.M. et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 289, 2801-2809 (2003).
28. Peiris, J.S.M. et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361, 1767-1772 (2003).
29. Fouchier, R.A. et al. Detection of influenza viruses from different species by PCR amplification of conserved sequences in the matrix gene. J. Clin. Microbiol. 38, 4096-5001 (2000).